Evaxion A/S

EVAX Nasdaq SEC CIK 1828253
Follow Evaxion Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2025 USD · IFRS
Revenue, last year $7.5M +125.1% vs prior year
Net income −$7.7M +27.1% vs prior year
EPS, diluted −$0.02 +90% vs prior year
Operating cash flow −$6.6M +48.8% vs prior year
Revenue by fiscal year
$0
$73K
$3.3M
$7.5M
FY22 FY23 FY24 FY25

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, IFRS
Revenue and net income9 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0$10MFY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$7.5M−$7.7M
FY24$3.3M−$10.6M
FY23$73K−$22.1M
FY22$0−$23.2M
FY21-−$24.5M
FY20-−$15M
FY19-−$11.2M
FY18-−$5.5M
FY17--
MarginsShare of revenue
  • Operating margin
  • Net margin
−40000%−30000%−20000%−10000%0%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearOperating marginNet margin
FY25−122.7%−102.4%
FY24−440.6%−316%
FY23−30406.8%−30308.2%
FY22--
FY21--
FY20--
FY19--
FY18--
FY17--
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$6.6M
FY24−$12.9M
FY23−$17.8M
FY22−$26.1M
FY21−$23.2M
FY20−$12.6M
FY19−$7.1M
FY18−$2M
FY17-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Evaxion
  • Healthcare median
−40000%−30000%−20000%−10000%0%FY17FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearEvaxionHealthcare median
FY25−102.4%−30.6%
FY24−316%−47%
FY23−30308.2%−58%
FY22-−80.4%
FY21-−71.8%
FY20-−62.2%
FY19-−46.2%
FY18-−49.6%
FY17-−45.9%